Billy Dunn
Impact in
- Psychiatry and Mental health top 2%
- Dementia and Cognitive Impairment Research
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Traumatic Brain Injury and Neurovascular Disturbances
Papers in
-
- Cerebrovascular and Carotid Artery Diseases 3
-
- Acute Ischemic Stroke Management 3
- Co-authors
- Peter Stein (1 shared paper)Patrizia Cavazzoni (1 shared paper)Charlotte E. Teunissen (2 shared papers)Reisa A. Sperling (2 shared papers)Philip Scheltens (2 shared papers)Thomas G. Beach (1 shared paper)Luca Pani (1 shared paper)Eric Siemers (1 shared paper)
- Journals
- Journal of Forensic Sciences (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Alzheimer s & Dementia (2 papers)Journal of Analytical Toxicology (2 papers)Frontiers in Pharmacology (1 paper)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Billy Dunn
19 papers receiving 1.6k citations
Billy Dunn's Hit Papers
Peers
Comparison fields: 5 of 117
- Psychiatry and Mental health 431
- Neurology 171
- Biological Psychiatry 43
- Physiology 370
- Health Informatics 17
Countries citing papers authored by Billy Dunn
This map shows the geographic impact of Billy Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billy Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billy Dunn more than expected).
Fields of papers citing papers by Billy Dunn
This network shows the impact of papers produced by Billy Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billy Dunn. The network helps show where Billy Dunn may publish in the future.
Co-authors
The 25 scholars most cited alongside Billy Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Hit paper breakdown → | 2024 | 1007 |
| 2 | Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective Hit paper breakdown → | 2021 | 184 |
| 3 | 2009 | 123 | |
| 4 | 2003 | 101 | |
| 5 | 2022 | 60 | |
| 6 | 2005 | 30 | |
| 7 | 1984 | 23 | |
| 8 | 1972 | 17 | |
| 9 | 2025 | 17 | |
| 10 | 2016 | 16 | |
| 11 | 2016 | 16 | |
| 12 | 1990 | 12 | |
| 13 | 2013 | 11 | |
| 14 | 1994 | 9 | |
| 15 | 2017 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2024 | 6 | |
| 18 | 2018 | 3 | |
| 19 | 2025 | 2 | |
| 20 | A Method for the Estimation of Drug Concentrations in Dried Bloodstains | 2007 | 0 |
About Billy Dunn
Billy Dunn is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology, Pharmacology and Economics and Econometrics, having authored 20 papers that have together received 1.7k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Acute Ischemic Stroke Management (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Computational Drug Discovery Methods (2 papers), Statistical Methods in Clinical Trials (2 papers), Stroke Rehabilitation and Recovery (2 papers) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Psychiatry and Mental health (431 citations), Neurology (171 citations), Biological Psychiatry (43 citations), Physiology (370 citations) and Health Informatics (17 citations). Billy Dunn has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Peter Stein, Patrizia Cavazzoni, Charlotte E. Teunissen, Reisa A. Sperling, Philip Scheltens, Thomas G. Beach, Luca Pani, Eric Siemers, Marı́a C. Carrillo and J. Scott Andrews. Their work appears in journals such as Journal of Forensic Sciences, Clinical Pharmacology & Therapeutics, Alzheimer s & Dementia, Journal of Analytical Toxicology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.